|
Volumn 371, Issue 9626, 2008, Pages 1800-1809
|
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADIPONECTIN;
ADVANCED GLYCATION END PRODUCT;
ANTIDIABETIC AGENT;
ANTILIPEMIC AGENT;
ARACHIDONIC ACID;
C REACTIVE PROTEIN;
CD36 ANTIGEN;
FIBRIC ACID DERIVATIVE;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERLEUKIN 1BETA;
INTERLEUKIN 6;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEMBRANE PROTEIN;
MONOCYTE CHEMOTACTIC PROTEIN 1;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PROSTAGLANDIN F2;
PROTEOGLYCAN;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
SUPEROXIDE;
TOLL LIKE RECEPTOR;
TRIACYLGLYCEROL;
ADIPOSE TISSUE;
ANTIINFLAMMATORY ACTIVITY;
ATHEROSCLEROSIS;
BLOOD VESSEL INJURY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CHRONIC INFLAMMATION;
CLINICAL TRIAL;
DYSLIPIDEMIA;
EXPERIMENTAL MOUSE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
INFLAMMATION;
LIPID METABOLISM;
LIPID OXIDATION;
MACROPHAGE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OXIDATIVE STRESS;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
REVIEW;
SMOOTH MUSCLE FIBER;
VASCULAR SMOOTH MUSCLE;
|
EID: 43849095463
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(08)60768-0 Document Type: Review |
Times cited : (459)
|
References (131)
|